INS and lung cancer: Putting together the findings of a lack of predictive power of insulin use on the mortality from lung cancer in our recent prospective 12-year follow-up study [31] and the lack of an association with the incidence of lung cancer in the present study (Table 2), the lung may also be one of those less sensitive organs.